Momelotinib is an ATP-competitive JAK1/JAK2 Inhibitor for Myelofibrosis Research
Primary myelofibrosis (PMF) is a myeloproliferative neoplasm (MPN) characterized by stem cell-derived clonal myeloproliferation. PMF disrupts the physiologic medullary erythropoietic environment and causes anemia symptoms. The JAK-STAT pathway plays a…